Droloxifene citrate is a selective estrogen receptor modulator structurally related to tamoxifen. It functions as a tissue-specific estrogen agonist and antagonist, exhibiting antiestrogenic activity in breast tissue while maintaining estrogenic effects on bone and lipid metabolism. It appears as a white to off-white crystalline powder, sparingly soluble in water but soluble in organic solvents including ethanol and methanol. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include 3-Hydroxytamoxifen citrate. Its PubChem CID is 3033766.
Droloxifene citrate
| CAS No | 97752-20-0 |
|---|---|
| Molecular Formula | C32H37NO9 |
| Molecular Weight | 579.6 g/mol |
| Synonyms | 3-[(E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Droloxifene citrate is a selective estrogen receptor modulator structurally related to tamoxifen. It functions as a tissue-specific estrogen agonist and antagonist, exhibiting antiestrogenic activity in breast tissue while maintaining estrogenic effects on bone and lipid metabolism.
The listed CAS number is 97752-20-0.
The listed molecular formula is C32H37NO9.
The listed molecular weight is 579.6 g/mol.
3-[(E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol;2-hydroxypropane-1,2,3-tricarboxylic acid.
The source lists 3-Hydroxytamoxifen citrate.